<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR4">
 <label>4.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Haioun</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Lepage</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Gisselbrecht</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Salles</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Coiffier</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Brice</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin’s lymphoma: final analysis of the prospective LNH87-2 protocol—a groupe d’Etude des lymphomes de l’Adulte study</article-title>
  <source>J Clin Oncol</source>
  <year>2000</year>
  <volume>18</volume>
  <fpage>3025</fpage>
  <lpage>30</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2000.18.16.3025</pub-id>
  <pub-id pub-id-type="pmid">10944137</pub-id>
 </element-citation>
</ref>
